Rhythm Pharmaceuticals (NASDAQ: RYTM) reported Q2 EPS of ($0.75), $0.08 worse than the analyst estimate of ($0.67).

For earnings history and earnings-related data on Rhythm Pharmaceuticals (RYTM) click here.